Publications of Felipe Tapia
All genres
Journal Article (8)
1.
Journal Article
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 2.
Journal Article
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 3.
Journal Article
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 4.
Journal Article
9, 26 (2018)
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in Immunology 5.
Journal Article
12 (8), e0182553 (2017)
Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems. PLoS One 6.
Journal Article
100 (5), pp. 2121 - 2132 (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and Biotechnology 7.
Journal Article
18 (3), pp. 147 - 167 (2014)
Magnesium-containing bioactive polycrystalline silicate-based ceramics and glass-ceramics for biomedical applications. Current Opinion in solid state & materials science 8.
Journal Article
32 (8), pp. 1003 - 1011 (2014)
Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine Meeting Abstract (2)
9.
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , October 06, 2019 - October 10, 2019. (2019)
10.
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
Talk (14)
11.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Plenarsitzung der Sächischen Akademie der Wissenschaften zu Leipzig, Leipzig, Germany (2020)
12.
Talk
Production of defective interfering particles of influenza A virus in continuously cultured bioreactors at two residence times - insights from within-host virus dynamics. 4th Workshop on Viral Dynamics, Paris, France (2019)
13.
Talk
Moderne Methoden der Impfstoffherstellung. Wissenschaft im Rathaus, Magdeburg, Germany (2019)
14.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Cuba Symposium “Frontiers of Science”, Havanna, Cuba (2019)
15.
Talk
Process Intensification in Viral Vaccine Manufacturing. International Symposium on Pharmaceutical Engineering Research – SPhERe, Braunschweig, Germany (2019)
16.
Talk
A universal platform for continuous manufacturing of viral vaccines and gene therapy vectors. 5. Workshop Bio-Verfahrenstechnik, Fraunhofer CBP Leuna, Germany (2019)
17.
Talk
A universal platform for continuous manufacturing of viral vaccines & gene therapy vectors. Workshop Bioverfahrenstechnik, Leuna, Germany (2019)
18.
Talk
A continuous tubular bioreactor for stable production of influenza virus vaccines. 25th ESACT Meeting, Lausanne, Switzerland (2017)
19.
Talk
A continuous tubular bioreactor for stable production of influenza virus vaccines. CChIQ2017: National Conference of Chemical Engineering, Santiago, Chile (2017)
20.
Talk
A continuous tubular bioreactor for stable production of influenza virus vaccines. SOMICH Coloquios de Microbiologia, Santiago, Chile (2017)